{"id":692779,"date":"2022-10-06T07:23:53","date_gmt":"2022-10-06T11:23:53","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles\/"},"modified":"2022-10-06T07:23:53","modified_gmt":"2022-10-06T11:23:53","slug":"evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles\/","title":{"rendered":"Evogene to Present at the LD Micro Main Event XV Investor Conference in Los Angeles"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n REHOVOT, Israel<\/span><\/span>, Oct. 6, 2022<\/span><\/span> \/PRNewswire\/ —\u00a0Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN) (the “Company<\/b>“, “Evogene<\/b>“), a leading computational biology company targeting to revolutionize life-science product discovery and development across multiple market segments, announced today that Ofer Haviv<\/span>, Evogene’s President and CEO, will attend and present at LD Micro Main Event, an investor conference taking place from Tuesday, October 25<\/span> to Wednesday, October 26, 2022<\/span>, in Los Angeles<\/span>. The event is a leading small cap investor conference, showcasing over 200 small- and micro-cap companies.<\/p>\n

\n \"Evogene\n <\/div>\n

\n Mr. Haviv\u00a0is scheduled to present on Tuesday, October 25<\/span> at 10am PT<\/span> in Track 4 and will be available for 1-1 meetings with investors throughout the conference.
<\/b>Mr. Haviv’s\u00a0presentation will focus on Evogene’s disruptive technologies, its AI (Artificial Intelligence) engines for biologic product discovery and development, and the ecosystem of product-focused subsidiaries and partnerships it has built around its technologies.<\/p>\n

Investors interested in attending and meeting directly with Mr. Haviv are welcome to contact Evogene’s Investor Relations team whose contact details are below or sign up via the LD Micro conference online meeting platform.<\/p>\n

\n About Evogene Ltd.:
<\/b>Evogene (Nasdaq: EVGN, TASE: EVGN) is a computational biology company aiming to revolutionize the development of life-science based products by utilizing cutting edge technologies to increase probability of success while reducing development time and cost. Evogene established three unique technological engines – MicroBoost\u00a0AI,\u00a0ChemPass AI and\u00a0GeneRator AI\u00a0\u2013 leveraging Big Data and Artificial Intelligence and incorporating deep multidisciplinary understanding in life sciences. Each technological engine\u00a0is focused on the discovery and development of products based on one of the following core components: microbes (MicroBoost AI), small molecules (ChemPass AI), and genetic elements (GeneRator AI). Evogene uses its technological engines to develop products through subsidiaries and with strategic partners. Currently,\u00a0Evogene’s main subsidiaries utilize the technological engines to develop human microbiome-based therapeutics by Biomica Ltd., medical cannabis products by Canonic Ltd., ag-chemicals by Ag Plenus Ltd. and ag-biologicals by Lavie Bio Ltd.\u00a0 For more information, please visit: www.evogene.com<\/a>.<\/p>\n

\n Evogene Investor Contact:\u00a0<\/b>\n <\/p>\n

\n Kenny Green<\/span>
\n
Email: Kenny.green@evogene.com<\/a>
Tel: +1 212 378 8040<\/p>\n

Logo – https:\/\/mma.prnewswire.com\/media\/890385\/Evogene_Logo.jpg<\/a><\/p>\n

\n \"Cision\" View original content:https:\/\/www.prnewswire.com\/news-releases\/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles-301642516.html<\/a><\/p>\n

SOURCE Evogene<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire REHOVOT, Israel, Oct. 6, 2022 \/PRNewswire\/ —\u00a0Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN) (the “Company“, “Evogene“), a leading computational biology company targeting to revolutionize life-science product discovery and development across multiple market segments, announced today that Ofer Haviv, Evogene’s President and CEO, will attend and present at LD Micro Main Event, an investor conference taking place from Tuesday, October 25 to Wednesday, October 26, 2022, in Los Angeles. The event is a leading small cap investor conference, showcasing over 200 small- and micro-cap companies. Mr. Haviv\u00a0is scheduled to present on Tuesday, October 25 at 10am PT in Track 4 and will be available for 1-1 meetings with investors throughout the conference. Mr. Haviv’s\u00a0presentation will focus on Evogene’s disruptive technologies, … <\/p>\n

Continue reading “Evogene to Present at the LD Micro Main Event XV Investor Conference in Los Angeles”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-692779","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nEvogene to Present at the LD Micro Main Event XV Investor Conference in Los Angeles - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Evogene to Present at the LD Micro Main Event XV Investor Conference in Los Angeles - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire REHOVOT, Israel, Oct. 6, 2022 \/PRNewswire\/ —\u00a0Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN) (the “Company“, “Evogene“), a leading computational biology company targeting to revolutionize life-science product discovery and development across multiple market segments, announced today that Ofer Haviv, Evogene’s President and CEO, will attend and present at LD Micro Main Event, an investor conference taking place from Tuesday, October 25 to Wednesday, October 26, 2022, in Los Angeles. The event is a leading small cap investor conference, showcasing over 200 small- and micro-cap companies. Mr. Haviv\u00a0is scheduled to present on Tuesday, October 25 at 10am PT in Track 4 and will be available for 1-1 meetings with investors throughout the conference. Mr. Haviv’s\u00a0presentation will focus on Evogene’s disruptive technologies, … Continue reading "Evogene to Present at the LD Micro Main Event XV Investor Conference in Los Angeles"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-06T11:23:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/890385\/Evogene_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Evogene to Present at the LD Micro Main Event XV Investor Conference in Los Angeles\",\"datePublished\":\"2022-10-06T11:23:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles\\\/\"},\"wordCount\":375,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/890385\\\/Evogene_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles\\\/\",\"name\":\"Evogene to Present at the LD Micro Main Event XV Investor Conference in Los Angeles - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/890385\\\/Evogene_Logo.jpg\",\"datePublished\":\"2022-10-06T11:23:53+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/890385\\\/Evogene_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/890385\\\/Evogene_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Evogene to Present at the LD Micro Main Event XV Investor Conference in Los Angeles\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Evogene to Present at the LD Micro Main Event XV Investor Conference in Los Angeles - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles\/","og_locale":"en_US","og_type":"article","og_title":"Evogene to Present at the LD Micro Main Event XV Investor Conference in Los Angeles - Market Newsdesk","og_description":"PR Newswire REHOVOT, Israel, Oct. 6, 2022 \/PRNewswire\/ —\u00a0Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN) (the “Company“, “Evogene“), a leading computational biology company targeting to revolutionize life-science product discovery and development across multiple market segments, announced today that Ofer Haviv, Evogene’s President and CEO, will attend and present at LD Micro Main Event, an investor conference taking place from Tuesday, October 25 to Wednesday, October 26, 2022, in Los Angeles. The event is a leading small cap investor conference, showcasing over 200 small- and micro-cap companies. Mr. Haviv\u00a0is scheduled to present on Tuesday, October 25 at 10am PT in Track 4 and will be available for 1-1 meetings with investors throughout the conference. Mr. Haviv’s\u00a0presentation will focus on Evogene’s disruptive technologies, … Continue reading \"Evogene to Present at the LD Micro Main Event XV Investor Conference in Los Angeles\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles\/","og_site_name":"Market Newsdesk","article_published_time":"2022-10-06T11:23:53+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/890385\/Evogene_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Evogene to Present at the LD Micro Main Event XV Investor Conference in Los Angeles","datePublished":"2022-10-06T11:23:53+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles\/"},"wordCount":375,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/890385\/Evogene_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles\/","name":"Evogene to Present at the LD Micro Main Event XV Investor Conference in Los Angeles - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/890385\/Evogene_Logo.jpg","datePublished":"2022-10-06T11:23:53+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/890385\/Evogene_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/890385\/Evogene_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-to-present-at-the-ld-micro-main-event-xv-investor-conference-in-los-angeles\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Evogene to Present at the LD Micro Main Event XV Investor Conference in Los Angeles"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/692779","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=692779"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/692779\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=692779"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=692779"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=692779"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}